A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of BMN 111 in Children with Achondroplasia

Project: Research project

Project Details

StatusFinished
Effective start/end date1/21/16 → 9/30/24

Funding

  • BioMarin Pharmaceutical Inc.